New eye drops aim to tackle blinding disease – first safety check in humans
Disease control
Completed
This early-stage study tested whether SCAI-005 eye drops are safe and how they move through the body in 48 healthy Korean adults. The goal is to develop a convenient eye drop treatment for wet age-related macular degeneration, a leading cause of vision loss. No results are availa…
Phase: PHASE1 • Sponsor: SCAI Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:02 UTC